ArticleOncotarget2015
A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myeloma.
Jingyu Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ArticleOncotarget2015
Jingyu Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.